Skip to main content

Thomas Lengauer

Thomas Lengauer, director at the Max Planck Institute for Informatics in Saarbrücken, has been elected as the next president of the International Society for Computational Biology (ISCB). He will take office as president-elect of the ISCB in January 2017 and will officially become president of the society in January 2018 taking over from current ISCB president Alfonso Valencia. Lengauer's term will end in January 2021. Lengauer will be the seventh president of the ISCB. He is a founding member of the society and currently serves as its vice president. He was named an ISCB fellow in 2015. He holds two doctoral degrees, one in mathematics from the Free University of Berlin, and one in computer science from Stanford University. His research interests lie in the field computational epigenomics, specifically, in understanding viral drug resistance. His lab has developed software that is used to select drug combinations for HIV patients.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.